Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-04

Clinical Trial Update: Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats [Phase 4]

View source ↗

Summary

Phase 4 study in rats evaluating the effects of lactoferrin on kidney and heart outcomes in rhabdomyolysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactoferrin (lactoferrin)

Snippet

Sponsor: Aswan University Hospital | Conditions: Rhabdomyolysis | Phase 4 | Status: COMPLETED